Literature DB >> 22530706

Menopausal symptoms appear before the menopause and persist 5 years beyond: a detailed analysis of a multinational study.

J E Blümel1, P Chedraui, G Baron, E Belzares, A Bencosme, A Calle, L Danckers, M T Espinoza, D Flores, G Gomez, J A Hernandez-Bueno, H Izaguirre, P Leon-Leon, S Lima, E Mezones-Holguin, A Monterrosa, D Mostajo, D Navarro, E Ojeda, W Onatra, M Royer, E Soto, K Tserotas, M S Vallejo.   

Abstract

OBJECTIVE: Few Latin American studies have described menopausal symptoms in detail by means of a standardized assessment tool. The objective of this study was to assess the prevalence and severity of menopausal symptoms and their impact over quality of life among mid-aged Latin American women.
METHOD: In this cross-sectional study, 8373 otherwise healthy women aged 40-59 years from 12 Latin American countries were asked to fill out the Menopause Rating Scale (MRS) and a questionnaire containing personal sociodemographic data. Menopause status (pre-, peri- and postmenopausal) was defined according to the criteria of the Stages of Reproductive Aging Workshop.
RESULTS: Of all the studied women, 90.9% had at least one menopausal symptom (complaint) that they rated. Muscle and joint discomfort, physical and mental exhaustion and depressive mood were highly prevalent and rated as severe-very severe (scores of 3 and 4), at a higher rate than vasomotor symptoms (15.6%, 13.8% and 13.7% vs. 9.6%, respectively). Of premenopausal women (40-44 years), 77.0% reported at least one rated complaint, with 12.9% displaying MRS scores defined as severe (> 16). The latter rate increased to 26.4% in perimenopausal, 31.6% in early postmenopausal and 29.9% among late postmenopausal women. As measured with the MRS, the presence of hot flushes increased the risk of impairment of overall quality of life in both premenopausal (odds ratio 12.67; 95% confidence interval 9.53-16.83) and peri/postmenopausal women (odds ratio 9.37; 95% confidence interval 7.85-11.19).
CONCLUSION: In this large, mid-aged, female Latin American series, muscle/joint discomfort and psychological symptoms were the most prevalent and severely rated menopausal symptoms. The symptoms appear early in the premenopause, significantly impair quality of life and persist 5 years beyond the menopause.

Entities:  

Mesh:

Year:  2012        PMID: 22530706     DOI: 10.3109/13697137.2012.658462

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.005


  13 in total

Review 1.  Correlates of palpitations during menopause: A scoping review.

Authors:  Janet S Carpenter; Ying Sheng; Caitlin Pike; Charles D Elomba; Jennifer S Alwine; Chen X Chen; James E Tisdale
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec

2.  The Association of Menopausal Symptoms and Social Support Among Saudi Women at Primary Health Care Centers in Taif, Saudi Arabia.

Authors:  Bashaer Aloufi; Noha S Hassanien
Journal:  Cureus       Date:  2022-06-20

3.  Bladder Symptoms in the Early Menopausal Transition.

Authors:  Holly J Jones; Alison J Huang; Leslee L Subak; Jeanette S Brown; Kathryn A Lee
Journal:  J Womens Health (Larchmt)       Date:  2016-01-07       Impact factor: 2.681

Review 4.  Review of menopausal palpitations measures.

Authors:  Ying Sheng; Janet S Carpenter; Charles D Elomba; Jennifer S Alwine; Min Yue; Caitlin A Pike; Chen X Chen; James E Tisdale
Journal:  Womens Midlife Health       Date:  2021-05-31

5.  Treatment of menopausal symptoms with three low-dose continuous sequential 17β-estradiol/progesterone parenteral monthly formulations using novel non-polymeric microsphere technology.

Authors:  Manuel Cortés-Bonilla; Roberto Bernardo-Escudero; Rosalba Alonso-Campero; María T Francisco-Doce; Marcelino Hernández-Valencia; Cuauhtémoc Celis-González; Ricardo Márquez-Oñate; Peter Chedraui; Juan A Uribe
Journal:  Gynecol Endocrinol       Date:  2015-06-10       Impact factor: 2.260

6.  Prevalence of somatic and urogenital symptoms as well as psychological health in women aged 45 to 55 attending primary health care: a cross-sectional study.

Authors:  Lena Rindner; Gunilla Strömme; Lena Nordeman; Margareta Wigren; Dominique Hange; Ronny Gunnarsson; Gun Rembeck
Journal:  BMC Womens Health       Date:  2017-12-08       Impact factor: 2.809

7.  Sensor-Based Smart Clothing for Women's Menopause Transition Monitoring.

Authors:  Jie Luo; Aihua Mao; Zhongwen Zeng
Journal:  Sensors (Basel)       Date:  2020-02-17       Impact factor: 3.576

Review 8.  Epidemiology of the symptoms of menopause - an intercontinental review.

Authors:  Marta Teresa Makara-Studzińśka; Karolina Maria Kryś-Noszczyk; Grzegorz Jakiel
Journal:  Prz Menopauzalny       Date:  2014-06-30

9.  Perimenopausal syndrome and mood disorders in perimenopause: prevalence, severity, relationships, and risk factors.

Authors:  Rui-Xia Li; Min Ma; Xi-Rong Xiao; Yan Xu; Xiu-Ying Chen; Bin Li
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

10.  Prognostic factors for future mental, physical and urogenital health and work ability in women, 45-55 years: a six-year prospective longitudinal cohort study.

Authors:  Lena Rindner; Lena Nordeman; Gunilla Strömme; Irene Svenningsson; Åsa Premberg; Dominique Hange; Ronny Gunnarsson; Gun Rembeck
Journal:  BMC Womens Health       Date:  2020-08-12       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.